2.Diagnosis and Treatment for Short Stature.
Journal of the Korean Pediatric Society 2003;46(Suppl 3):S353-S362
No abstract available.
Diagnosis*
3.Pathopysiology of Renovascular Hypertension.
Journal of the Korean Society for Vascular Surgery 2000;16(1):149-153
No abstract available.
Hypertension, Renovascular*
4.Management of Children with Short Stature.
Journal of Korean Society of Endocrinology 2003;18(6):561-570
5.Pharmacological Treatment Strategies for Alzheimer's Disease.
Journal of the Korean Medical Association 2002;45(4):401-408
Alzheimer's disease(AD) is one of the most common causes of mental deterioration in elderly individuals, accounting for around 45~60% of the overall cases of dementia over 65 years of age. Although there is presently no "cure" for AD, a large number of potential therapeutic interventions have emerged to correct cholinergic dysfunctions. Currently, cholinergic therapy, particularly cholinesterase inhibition, represents the most realistic approach to the symptomatic treatment of AD. Modest efficacy for mild to moderate AD has been shown in well-designed clinical trials for tacrine, donepezil, rivastigmine, and galantimine. Among other treatment options, estrogen replacement therapy in postmenopausal women is under active investigation, but recent studies showed somewhat disappointing results. Epidemiological and clinical data suggest that nonsteroidal anti-inflammatory drugs are beneficial in the treatment and prevention of AD. But prednisone and COX-2 inhibitor, celecoxib showed no clinical benefit in recent studies. Alpha-tocopherol and gingko biloba showed some beneficial effect in delaying the progression of AD and enhancing cognitive functions. Immunization with beta amyloid peptide was considered to be the only method to prevent and halt disease progression in patients with AD. Recently, phase II clinical trial using synthetic beta amyloid peptide (AN-1792) was discontinued because some patients showed neuro-inflammation which may be caused by autoimmune responses.
Aged
;
alpha-Tocopherol
;
Alzheimer Disease*
;
Amyloid
;
Autoimmunity
;
Celecoxib
;
Cholinesterases
;
Cognition
;
Dementia
;
Disease Progression
;
Estrogen Replacement Therapy
;
Female
;
Ginkgo biloba
;
Humans
;
Immunization
;
Methods
;
Prednisone
;
Rivastigmine
;
Tacrine
6.Insulin Therapy in Insulin Dependent Diabetes Mellitus.
Journal of Korean Society of Pediatric Endocrinology 1999;4(2):141-146
No abstract available.
Diabetes Mellitus*
;
Insulin*
7.The Growth Hormone Response to Growth Hormone-Releasing Hexapeptide (GHRP-6) in the Sprague Dawley Rat with Hypothyroidism.
Journal of the Korean Pediatric Society 1994;37(1):89-98
No abstract available.
Animals
;
Growth Hormone*
;
Hypothyroidism*
;
Rats*
8.Growth Hormone-Releasing Hexapeptide (GHRP-6)
Journal of Korean Society of Endocrinology 1995;10(1):1-9
No abstract available.
9.The variability of growth hormone(GH) response to growth hormone-releasing hormone(GHRH) according to the intrinsic growth hormone secretory rhythm in children with normal growth hormone reserve.
Journal of the Korean Pediatric Society 1993;36(3):312-319
The diagnostic value of GHRH in assessing GH secretion in biochemical GH sufficient short children was examined. GHRH (1microgram/kg i.v bolus) was given to three groups (upslope, trough, downslope) arbitrarily classified according to the basal pulsatile GH secretory pattern before GHRH administration. Cmax following GHRH administration were variable and overlapping. Two children in downslope group, three children in trough group, and one child in upslope group showed subnormal GH responses to GHRH administration despite of normal GH response to more than two classical GH provocative tests (Fig.1). The time of maximal GH response after GHRH administration (Tmax) in upslope group was significantly faster than those in other two groups (Fig.2). There was a highly significant correlation between AUC and Cmax (p<0.001) after GHRH administration (Fig.3) which suggests that AUC or Cmax can be used for parameters of GH response to GHRH each other. The AUC and Cmax after GHRH administration between three groups were significantly different (2764+/-579.1ng/ml min, 52.6 ng/ml, respectively in upslope group; 1645+/-383.9ng/ml min, 37.7+/-9.4ng/ml, respectively in downslope group; 1098+/-150.2ng/ml min, 26.3+/-4.5ng/ml, respectively in trough group)(p<0.005) (Fig.4, Table 1). In conclusion, GH responses to GHRH adminstration could be variable according to the basal GH secretory rhythm. Therefore, we should be cautious in interpreting the GH response to GHRH to evaluate the GH secretory capacity because subnormal GH response to GHRH administration could be observed even if normal GH response to classical GH provocative tests. In addition, the classification of these arbitary three groups (upslope, trough, and downslope) is remained to defined so as to promote the diagnostic value of GHRH in GH deficiency.
Area Under Curve
;
Child*
;
Classification
;
Growth Hormone*
;
Humans
10.Studiedies on the Pollution Bacteria in the River Water of Baek Ma.
Korean Journal of Preventive Medicine 1974;7(1):175-176
The purpose of this study was to survey bacteria which was known as a fecal bacteria living in the human and animal gastro and intestinal tract. The colony density of the fecal coliform and fecal streptococci was 280 and 130 in 100ml sample amounts respectively. Staphylococcus aureus and Pseudomonas aeruginosa which is usually exist in swimming pool and was known as indicator of the pool water contamination was detected.
Animals
;
Bacteria*
;
Humans
;
Pseudomonas aeruginosa
;
Rivers*
;
Staphylococcus aureus
;
Swimming Pools